Douglas Miehm
Stock Analyst at RBC Capital
(0)
# 4518
Out of 5,354 analysts
44
Total ratings
35.71%
Success rate
-13.54%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
LGND Ligand Pharmaceutica... | Maintains: Outperform | 130 140 | 103.07 | 35.83% | 4 | Nov 12, 2024 | |
BHC Bausch Health Compan... | Maintains: Sector Perform | 10 11 | 4.66 | 136.05% | 18 | Nov 1, 2024 | |
BLCO Bausch & Lomb | Maintains: Outperform | 20 23 | 11.54 | 99.31% | 10 | Oct 22, 2024 | |
AUPH Aurinia Pharmaceutic... | Maintains: Outperform | 13 8 | 8.04 | -0.5% | 9 | Feb 16, 2024 | |
CRHM CRH Medical | Downgrades: Sector Perform | n/a | n/a | n/a | 1 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | n/a | n/a | n/a | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jul 20, 2016 |